Re: Magnesium sulfate: role as possible attenuating factor in vasospasm morbidity (Prevedello DM et al. Surg Neurol 2006;65:S1:14-S1:21)

Surgical Neurology

Volumn 66, Issue 1, 2006, Pages 110-

  Wong, George K C ^a   Poon, Wayne W S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE;

BRAIN ARTERY ANEURYSM; BRAIN ISCHEMIA; BRAIN SURGERY; BRAIN VASOSPASM; CLINICAL TRIAL; DRUG INFUSION; HUMAN; INCIDENCE; LETTER; MORBIDITY; OUTCOME ASSESSMENT; TREATMENT OUTCOME;

CEREBRAL ARTERIES; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; MAGNESIUM SULFATE; REPRODUCIBILITY OF RESULTS; SAMPLE SIZE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASODILATOR AGENTS; VASOSPASM, INTRACRANIAL;

EID: 33745184433     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2006.04.004     Document Type: Letter

References (3)

1. Boet R., Chan M.T., Poon W.S., Wong G.K., Wong H.T., and Gin T. Intravenous magnesium sulphate to improve outcome after aneurysmal subarachnoid hemorrhage. Acta Neurochir Suppl 95 (2005) 263-264
2. Van den Bergh W.M., and on behalf of the MASH Study Group. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 36 5 (2005) 1011-1015
3. Veyna R.S., Seyfried D., Burke D.G., Zimmerman C., Mlynarek M., Nichols V., Marrocco A., Thomas A.J., Mitsias P.D., and Malik G.M. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96 (2002) 510-514